Source: FDA, National Drug Code (US)
RESCULA (unoprostone isopropyl ophthalmic solution) 0.15% is indicated for the lowering of intraocular pressure in patients with open-angle glaucoma or ocular hypertension who are intolerant of other intraocular pressure lowering medications or insufficiently responsive (failed to achieve target IOP determined after multiple measurements over time) to another intraocular pressure lowering medication.
The recommended dosage is one drop in the affected eye(s) twice daily. RESCULA may be used concomitantly with other topical ophthalmic drug products to lower intraocular pressure. If two drugs are used, they should be administered at least five minutes apart.
There is no published information available regarding overdosage with RESCULA 0.15%. The risk of adverse effects due to accidental oral ingestion is very low since the amount of active ingredient in each bottle is limited (7.5 mg in a 5 mL vial). Accidental ingestion of a vial by a child with 30 kg body weight will amount to 0.25 mg/kg body weight.
If overdosage does occur, treatment should be symptomatic.
Store between 2°-25°C (36°-77°F).
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
